Topical mitomycin-c for subepithelial fibrosis after refractive corneal surgery

Ophthalmology

Volumn 107, Issue 1, 2000, Pages 89-94

  Majmudar, Parag A ^a   Forstot, S Lance ^b   Dennis, Richard F ^a   Nirankari, Verinder S ^c   Damiano, Richard E ^b   Brenart, Robert ^d   Epstein, Randy J ^a  

^a Dept of Ophthalmology R ^*  (United States)

^b NONE   (United States)

^c Eye Consultants of Maryland   (United States)

^d Brenart Eye Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CORNEA SURGERY; DRUG EFFICACY; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; KERATECTOMY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; DEBRIDEMENT; EPITHELIUM, CORNEAL; FEMALE; FIBROSIS; HUMANS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; KERATOTOMY, RADIAL; MALE; MIDDLE AGED; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; REFRACTIVE ERRORS; TREATMENT OUTCOME; VISUAL ACUITY; WOUND HEALING;

EID: 0034114279     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00019-6     Document Type: Article

References (25)

1. Waring G.O. III, Rodrigues M.M. Patterns of pathologic response in the cornea. Surv Ophthalmol. 31:1987;262-266.
2. Bechara S.J., Grossniklaus H.E., Waring G.O. III. Subepithelial fibrosis after myopic epikeratoplasty report of a case . Arch Ophthalmol. 110:1992;228-232.
3. Hanna K.D., Pouliquen Y.M., Waring G.O. III, et al. Corneal wound healing in monkeys after repeated excimer laser photorefractive keratectomy. Arch Ophthalmol. 110:1992;1286-1291.
4. Geggel H.S. Effect of peripheral subepithelial fibrosis on corneal transplant topography. J Cataract Refract Surg. 22:1996;135-138.
5. Calabresi P., Chabner B.A. Antineoplastic agents. Goodman Gilman A., Rall T.W., Nies A.S., Taylor P., Pharmacological Basis of Therapeutics. 8th ed. 1990;1247-1248 Pergamon Press, New York.
6. Sugar A. Who should receive mitomycin-C after pterygium surgery? [editorial]. Ophthalmology. 99:1992;1645-1646.
7. Palmer S.S. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 98:1991;317-321.
8. Singh G., Wilson M.R., Foster C.S. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 95:1988;813-821.
9. Mahar P.S., Nwokora G.E. Role of mitomycin C in pterygium surgery. Br J Ophthalmol. 77:1993;433-435.
10. Kraut A., Drnovsek-Olup B. Instillation of mitomycin C after recurrent pterygium surgery. Eur J Ophthalmol. 6:1996;264-267.
11. Helal M., Messiha N., Amayem A., et al. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. Ophthalmic Surg Lasers. 27:1996;674-678.
12. Frucht-Pery J., Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 117:1994;164-168.
13. Wilson M.W., Hungerford J.L., George S.M., Madreperla S.A. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 124:1997;303-311.
14. Heigle T.J., Stulting R.D., Palay D.A. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol. 124:1997;397-399.
15. Donnenfeld E.D., Perry H.D., Wallerstein A., et al. Subconjunctival Mitomycin C for the Treatment of Ocular Cicatricial Pemphigoid. Ophthalmology. 106:1999;72-79.
16. Talamo J.H., Gollamudi S., Green W.R., et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 109:1991;1141-1146.
17. Schipper I., Suppelt C., Gebbers J.O. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye. 11:1997;649-655.
18. Gieser J., Sugar A. Radial keratotomy and corneal scarring [letter]. Arch Ophthalmol. 110:1992;1527-1528.
19. Nirankari V.S., Katzen L.E., Richards R.D., et al. Prospective clinical study of radial keratotomy. Ophthalmology. 89:1982;677-683.
20. Dushku N., Reid T.W. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res. 13:1994;473-481.
21. Fujitani A., Hayasaka S., Shibuya Y., Noda S. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica. 207:1993;162-164.
22. Rubinfeld R.S., Pfister R.R., Stein R.M., et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 99:1992;1647-1654.
23. Dougherty P.J., Hardten D.R., Lindstrom R.L. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 15:1996;537-540.
24. Cardillo J.A., Alves M.R., Ambrosio L.E., et al. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology. 102:1995;1949-1952.
25. Frucht-Pery J., Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pteryigium. Ophthalmology. 101:1994;759-762.